Revenue of approximately $166.0 million for the three months ended December 31, 2025, representing 11% growth sequentially and 1% growth compared to the corresponding prior year period. Instruments ...
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth ...
Okay. Thanks, everybody, for joining us today. My name is Casey Woodring from the Life Science Tools and Diagnostics team. Welcome to the JPMorgan Healthcare Conference. Pleased to be joined today by ...
Old Mutual Wealth has acquired the green light to acquire 10X Investments from the Competition Commission. The commission recommended that the Competition Tribunal approve the proposed transaction ...
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results